مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

101
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

57
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Double-stranded RNA Activated Caspase Oligomerizer (DRACO): Designing, Subcloning, and Antiviral Investigation

Author(s)

Sharti Mojtaba | ESMAEILI GOUVARCHIN GHALEH HADI | JALALI KONDORI BAHMAN | DOROSTKAR RUHOLLAH | Issue Writer Certificate 

Pages

  46-50

Abstract

 Introduction: Antiviral therapy  is an alternative for viral infection control when the virus is identified. As antiviral therapy has effectively used basic science to create very efficient treatments for severe viral infections, it is one of the most promising virology aspects. In the present study, a novel broad-spectrum antiviral method, dubbed Double-stranded RNA (dsRNA) activated caspase oligomerizer (DRACO) have been developed, which induces apoptosis in cells with viral dsRNA selectively to rapidly kill infected cells with no damage to uninfected ones. Materials and Methods: Following the design, development, expression, and purification of DRACO, the influenza virus-infected MDCK and uninfected MDCK Cells were treated with 40, 60, and 80 mg/L concentration of DRACO to study its potential antiviral activity. Then, TCID50 (50% tissue culture infectious dose) of the virus, together with the viability of cells, was measured. Results: The findings of the present study showed that DRACO is nontoxic to uninfected MDCK Cells and is effective for H1N1 influenza virusinfected MDCK Cells dose-dependently. Also, the infected MDCK Cells treated with DRACO have shown a significant reduction in TCID50 compared with the control group. Conclusions: The outcomes suggest that DRACO has a potential as a new anti-H1N1 therapeutic drug that its in-vivo antiviral efficacy requires to be examined through a clinical analysis of large quantities of animal models.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    Sharti, Mojtaba, ESMAEILI GOUVARCHIN GHALEH, HADI, JALALI KONDORI, BAHMAN, & DOROSTKAR, RUHOLLAH. (2021). Double-stranded RNA Activated Caspase Oligomerizer (DRACO): Designing, Subcloning, and Antiviral Investigation. JOURNAL OF APPLIED BIOTECHNOLOGY REPORTS, 8(1), 46-50. SID. https://sid.ir/paper/681049/en

    Vancouver: Copy

    Sharti Mojtaba, ESMAEILI GOUVARCHIN GHALEH HADI, JALALI KONDORI BAHMAN, DOROSTKAR RUHOLLAH. Double-stranded RNA Activated Caspase Oligomerizer (DRACO): Designing, Subcloning, and Antiviral Investigation. JOURNAL OF APPLIED BIOTECHNOLOGY REPORTS[Internet]. 2021;8(1):46-50. Available from: https://sid.ir/paper/681049/en

    IEEE: Copy

    Mojtaba Sharti, HADI ESMAEILI GOUVARCHIN GHALEH, BAHMAN JALALI KONDORI, and RUHOLLAH DOROSTKAR, “Double-stranded RNA Activated Caspase Oligomerizer (DRACO): Designing, Subcloning, and Antiviral Investigation,” JOURNAL OF APPLIED BIOTECHNOLOGY REPORTS, vol. 8, no. 1, pp. 46–50, 2021, [Online]. Available: https://sid.ir/paper/681049/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button